Iberogast Select

Bitter Candytuft Fresh Plant Extract, the active ingredient in Iberogast Select, is a herbal medicine presented as a liquid oral preparation for oral use. It treats functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort in adults.

GNH USA supplies Iberogast Select as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Iberogast Select is used to manage functional gastrointestinal disorders.

Functional dyspepsia: reduces upper abdominal discomfort, bloating and early satiety. Irritable bowel syndrome: alleviates abdominal pain, cramping and irregular bowel habits. Gastro‑intestinal discomfort: provides carminative relief of gas, flatulence and mild diarrhoea.

Adverse reactions are generally mild and reversible.

Common Side Effects: - Altered taste sensation - Mild nausea - Increased flatulence - Loose stools or mild diarrhoea - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria or angioedema - Hepatic enzyme elevation - Severe abdominal pain unresponsive to usual therapy - Anaphylactic shock (rare) - Eosinophilic gastroenteritis reported in isolated cases

Before using Iberogast Select, consider the following safety points.

Pregnancy: safety not established; avoid unless prescribed. Breastfeeding: insufficient data; use with caution. Children: not recommended unless directed by a healthcare professional. Known hypersensitivity to any herbal component: discontinue immediately. Concurrent use with other antispasmodic or herbal products: monitor for additive effects. Store below 25°C: keep in the original pack, protect from moisture.

Potential drug interactions should be reviewed prior to therapy.

Major Interactions (Avoid): - Concomitant use with anticoagulants may increase bleeding risk. - Use with other herbal preparations containing similar active constituents may amplify adverse reactions.

Moderate Interactions (Monitor Closely): - Combination with antacids may alter the absorption of herbal constituents. - Co‑administration with prokinetic agents could produce additive gastrointestinal effects. - Interaction with monoamine oxidase inhibitors (e.g., peppermint‑containing products) may precipitate hypertensive episodes.